Versant Ventures
Overview
Versant Ventures is a leading healthcare investment firm committed to helping exceptional entrepreneurs build the next generation of great companies . The firm's emphasis is on biotechnology companies that are discovering and developing novel therapeutics . With offices in the U.S., Canada and Europe, Versant has built a team with deep investment, operating and R&D expertise that enables a hands-on approach to company building .
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Dayra Therapeutics | Nov 2025 | Series A | Lead |
| Gate Bioscience | Nov 2025 | Series B | Co-investor |
| AllRock Bio | Sep 2025 | Series A | Lead |
| Dualitas Therapeutics | Sep 2025 | Series A | Lead |
| Granite Bio | Apr 2025 | VC Round | Lead |
Key People
Barbara Lubash
Managing Director (Emeritus) And Co-Founder
Beckie Robertson
Founder And General Partner
Don Milder
Managing Partner
Brad Bolzon
Chairman and Managing Director
Carlo Rizzuto
Managing Director
Clare Ozawa
Managing Director
Jerel Davis
Managing Director
Robin Praeger
Managing Director/Advisor
Tom Woiwode
Managing Director
Giorgio Ottaviani
Operating Partner
Kevin Grove
Venture Partner
Markus Warmuth
Venture Partner
Nigel Sheail
Venture Partner
Thomas Hudson
Venture Partner
Zachary Sweeney
Venture Partner
Markus Enzelberger
Partner
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
